View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2...

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024 MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Tuesday, May 7, 2024. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on May 7th beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-register f...

 PRESS RELEASE

Parsons Reports Strong First Quarter 2024 Results

Parsons Reports Strong First Quarter 2024 Results Q1 2024 Financial Highlights Record revenue of $1.5 billion increases 31% year-over-yearRecord first quarter organic revenue growth of 29%, including four consecutive quarters with organic growth above 20%Net loss of $107 million due to a $214 million pre-tax charge related to a partial repurchase of 2025 convertible notes above par due to stock price appreciationAdjusted EBITDA increases by 56% to $141 millionStrong book-to-bill ratio of 1.4x on record contract awards with 51% growthRecord total backlog increases 8% to $9.0 billionIncreasi...

 PRESS RELEASE

Parsons Wins Position on $464M U.S. Army Remediation Contract

Parsons Wins Position on $464M U.S. Army Remediation Contract CHANTILLY, Va., April 29, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company was awarded a position on an indefinite-delivery, indefinite-quantity (IDIQ) multiple award task order contract (MATOC) by the United States Army Environmental Command (USAEC) for remediation services at sites involving hazardous toxic waste, including perfluoroalkyl and polyfluoroalkyl substances (PFAS). The $464 million ceiling value contract consists of a five-year ordering period and is new work for the compan...

 PRESS RELEASE

Parsons Increasing Production of U.S. Air Force’s RADBO System

Parsons Increasing Production of U.S. Air Force’s RADBO System The company was awarded a $63 million contract modification CHANTILLY, Va., April 25, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company has been awarded a $63 million, firm-fixed-price contract modification to its Recovery of Airbase Denied by Ordnance (RADBO) production contract by the U.S. Air Force Life Cycle Management Center. This modification brings the total number of Air Force RADBO systems to 29. The RADBO system, which includes Parsons' ZEUS® directed energy system, prov...

 PRESS RELEASE

Northrim BanCorp Earns $8.2 Million, or $1.48 Per Diluted Share, in Fi...

Northrim BanCorp Earns $8.2 Million, or $1.48 Per Diluted Share, in First Quarter 2024 ANCHORAGE, Alaska, April 24, 2024 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ:NRIM) (“Northrim” or the “Company”) today reported net income of $8.2 million, or $1.48 per diluted share, in the first quarter of 2024, compared to $6.6 million, or $1.19 per diluted share, in the fourth quarter of 2023, and $4.8 million, or $0.84 per diluted share, in the first quarter a year ago. The increase in first quarter 2024 profitability as compared to the prior quarter was primarily the result of an increase ...

 PRESS RELEASE

Noodles & Company to Announce First Quarter 2024 Results on May 8, 202...

Noodles & Company to Announce First Quarter 2024 Results on May 8, 2024 BROOMFIELD, Colo., April 18, 2024 (GLOBE NEWSWIRE) -- Noodles & Company (NASDAQ: NDLS) today announced that it will host a conference call to discuss its first quarter 2024 financial results on Wednesday, May 8, 2024 at 4:30 p.m. ET. Drew Madsen, Chief Executive Officer, and Mike Hynes, Chief Financial Officer, will host the call. A press release with first quarter 2024 financial results will be issued after the market close that same day. To access the live conference call, please click on the registration link t...

 PRESS RELEASE

Martin Midstream Partners Reports First Quarter 2024 Financial Results...

KILGORE, Texas--(BUSINESS WIRE)-- Martin Midstream Partners L.P. (Nasdaq: MMLP) (“MMLP” or the “Partnership”) today announced its financial results for the first quarter of 2024. Bob Bondurant, President and Chief Executive Officer of Martin Midstream GP LLC, the general partner of the Partnership, stated, “The Partnership had a strong quarter resulting in adjusted EBITDA of $30.4 million compared to guidance of $31.6 million. Demand in both the marine and land transportation divisions remain robust leading to outperformance in the transportation segment when compared to our forecast. Howeve...

 PRESS RELEASE

Parsons Selected to Design the Future Newark Bay Bridge, Advancing Tra...

Parsons Selected to Design the Future Newark Bay Bridge, Advancing Transportation throughout New Jersey CHANTILLY, Va., April 15, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the New Jersey Turnpike Authority selected the company to serve as final designer for the replacement of the Vincent Robert Casciano Bridge, known as the Newark Bay Bridge. The final design is the first final design contract of the Newark Bay-Hudson County Extension Improvements Program, a critical modernization and safety program that will rebuild the 8.1-mile NJ Turnpike Extension f...

David Carlson ... (+8)
  • David Carlson
  • David Nierengarten
  • Dennis Pak
  • Laura Chico
  • Martin Fan
  • Ritika Das
  • Robert Driscoll
  • Sam Ravina
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VRTX VERTEX PHARMACEUTICALS INCORPORATED
SRPT SAREPTA THERAPEUTICS INC.
SGMO SANGAMO THERAPEUTICS INC.
SAGE SAGE THERAPEUTICS INC.
RGNX REGENXBIO INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PCRX PACIRA BIOSCIENCES INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MNKD MANNKIND CORP.
LL LUMBER LIQUIDATORS HOLDINGS INC.
KURA KURA ONCOLOGY INC.
HD HOME DEPOT INC.
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
CMRX CHIMERIX INC
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
TSC TRISTATE CAPITAL HOLDINGS INC
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
NTLA INTELLIA THERAPEUTICS INC.
PK PARK HOTELS & RESORTS INC.
ANAB ANAPTYSBIO INC.
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
OVID OVID THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
VRNA VERONA PHARMA ADS
SE SEA ADS
AMD ADVANCED MICRO DEVICES INC.
APLS APELLIS PHARMACEUTICALS
UBX UNITY BIOTECHNOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
AX AXOS FINANCIAL INC.
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
IMUX IMMUNIC INC
GOSS GOSSAMER BIO
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
APRE APREA THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
RVMD REVOLUTION MEDICINES
PASG PASSAGE BIO
ACET ADICET BIO INC
ASO ACADEMY SPORTS AND OUTDOORS
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
BEAM BEAM THERAPEUTICS
GBIO GENERATION BIO
PRAX PRAXIS PRECISION MEDICINES
COGT COGENT BIOSCIENCES INC
VOR VOR BIOPHARMA
NUVB NUVATION BIO INC (A)
CGEM CULLINAN ONCOLOGY INC
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
OMGA OMEGA THERAPEUTICS
SBTX SILVERBACK THERAPEUTICS
TNGX TANGO THERAPEUTICS
LBPH INC
IKNA LONGBOARD PHARMACEUTICALS
TCRX IKENA ONCOLOGY INC
VERA TSCAN THERAPEUTICS INC
HOWL VERA THERAPEUTICS INC
GLUE WEREWOLF THERAPEUTICS INC
AVTE MONTE ROSA THERAPEUTICS INC
CMPX AEROVATE THERAPEUTICS INC
GMTX COMPASS THERAPEUTICS
JANX GEMINI THERAPEUTICS INC
VIGL JANUX THERAPEUTICS INC
MLTX VIGIL NEUROSCIENCE INC
TYRA MOONLAKE IMMUNOTHERAPEUTICS
PEPG TYRA BIOSCIENCES INC
HR PEPGEN INC
EWTX HEALTHCARE TRUST OF AMERICA INC.
PRME EDGEWISE THERAPEUTICS INC
OCS PRIME MEDICINE INC
APGE OCULIS HOLDING AG
DNTH APOGEE THERAPEUTICS INC
DIANTHUS THERAPEUTICS INC
 PRESS RELEASE

Parsons to Support Clients in Addressing PFAS and Achieving EPA’s Nati...

Parsons to Support Clients in Addressing PFAS and Achieving EPA’s National PFAS Drinking Water Regulations CHANTILLY, Va., April 11, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN), an industry leading Per and Polyfluoroalkyl Substances (PFAS) investigation and remediation company, is ready to support our current and future clients in addressing PFAS and achieving the U.S. Environmental Protection Agency’s (EPA) first-ever national regulations for PFAS in drinking water. Parsons has advised clients around the world on PFAS investigation and remediation challenges for more than 15...

 PRESS RELEASE

Parsons Included on $200M U.S. Army Corps of Engineers Construction Ma...

Parsons Included on $200M U.S. Army Corps of Engineers Construction Management Contract CHANTILLY, Va., April 11, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company was included on a $200 million indefinite-delivery, indefinite-quantity multiple award task order contract by the United States Army Corps of Engineers (USACE) Fort Worth District. The construction management services contract has a three-year base period of performance with two, two-year option periods and represents new work for the company. Under this contract, Parsons will compete fo...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Long-Term Breakouts for Emerging & Frontier Markets The bullish outlook we initiated in early November 2023 remains intact. The S&P 500 and Nasdaq 100 (QQQ) still refuse to close below their 20-day MAs/21-day EMAs for more than 2-3 consecutive days -- and even if/when they do, important supports are close by, including at 4983-5050 on the S&P 500 and $425-$433 on QQQ (gap supports from 2/22/24). The Fed's next move is almost guaranteed to be a cut (though when it happens is up for debate). And ...

 PRESS RELEASE

Parsons to Announce First Quarter 2024 Financial Results on May 1, 202...

Parsons to Announce First Quarter 2024 Financial Results on May 1, 2024 CHANTILLY, Va., April 09, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE:PSN) will release first quarter 2024 financial results before the markets open on Wednesday, May 1, 2024. The company will host a conference call at 8:00 a.m. Eastern Time that day to discuss its earnings results and strategic corporate initiatives. Access to a webcast of the live conference call can be obtained through the Investor Relations section of the company's website (). Those parties interested in participating via telephone may reg...

 PRESS RELEASE

Martin Midstream Partners L.P. Sets Date for Release of First Quarter ...

KILGORE, Texas--(BUSINESS WIRE)-- Martin Midstream Partners L.P. (NASDAQ: MMLP) (“MMLP”) will announce its financial results for the first quarter of 2024 on Wednesday, April 17, 2024, after the market closes. An investors’ conference call to review first quarter results will be held the following day. Date: Thursday, April 18, 2024 Time: 8:00 a.m. CT (please dial in by 7:55 a.m.) Dial In #: (888) 330-2384 Conference ID: 8536096 Replay Dial In # (800) 770-2030 – Conference ID: 8536096 Pre-registration for the event and a webcast of the conference call is also available by visiting the Ev...

 PRESS RELEASE

Parsons Awarded Position on $1B NNSA Counter Nuclear Smuggling System ...

Parsons Awarded Position on $1B NNSA Counter Nuclear Smuggling System Deployment Contract CHANTILLY, Va., April 03, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company was awarded a position on an indefinite-delivery, indefinite-quantity multiple award task order contract by the National Nuclear Security Administration’s (NNSA’s) Office of Nuclear Smuggling Detection and Deterrence (NSDD). The $1 billion ceiling value contract to deploy advanced counter-nuclear smuggling systems globally includes a three-year base period of performance and two, two-ye...

Wedbush Research
  • Wedbush Research
2454 MEDIATEK INC.
MTB M&T BANK CORPORATION
VMW VMWARE INC. CLASS A
BLUE BLUEBIRD BIO INC.
ZION ZIONS BANCORPORATION N.A.
WTFC WINTRUST FINANCIAL CORPORATION
WDC WESTERN DIGITAL CORPORATION
WBS WEBSTER FINANCIAL CORPORATION
WAL WESTERN ALLIANCE BANCORP
VYGR VOYAGER THERAPEUTICS INC.
VLY VALLEY NATIONAL BANCORP
TCBI TEXAS CAPITAL BANCSHARES INC.
SRPT SAREPTA THERAPEUTICS INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SGMO SANGAMO THERAPEUTICS INC.
SBUX STARBUCKS CORPORATION
RGNX REGENXBIO INC.
RF REGIONS FINANCIAL CORPORATION
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
PPBI PACIFIC PREMIER BANCORP INC.
PB PROSPERITY BANCSHARES INC.(R)
PAYX PAYCHEX INC.
NYCB NEW YORK COMMUNITY BANCORP INC.
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
MNKD MANNKIND CORP.
KEY KEYCORP
INTC INTEL CORPORATION
HMST HOMESTREET INC.
HBI HANESBRANDS INC.
HBAN HUNTINGTON BANCSHARES INCORPORATED
HAFC HANMI FINANCIAL CORPORATION
GOOGL ALPHABET INC. CLASS A
FITB FIFTH THIRD BANCORP
FHN FIRST HORIZON CORPORATION
FFWM FIRST FOUNDATION
EWBC EAST WEST BANCORP INC.
CVBF CVB FINANCIAL CORP.
CUBI CUSTOMERS BANCORP INC.
COLB COLUMBIA BANKING SYSTEM INC.
CFG CITIZENS FINANCIAL GROUP INC.
CATY CATHAY GENERAL BANCORP
BMRN BIOMARIN PHARMACEUTICAL INC.
BKU BANKUNITED INC.
BIIB BIOGEN INC.
BANC BANC OF CALIFORNIA INCORPORATED
AXTI AXT INC.
NFLX NETFLIX INC.
CFR CULLEN/FROST BANKERS INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
BOKF BOK FINANCIAL CORPORATION
CMA COMERICA INCORPORATED
SLM SLM CORP
HPE HEWLETT PACKARD ENTERPRISE CO.
NTLA INTELLIA THERAPEUTICS INC.
HOPE HOPE BANCORP INC.
FCNCA FIRST CITIZENS BANCSHARES INC. CLASS A
ROKU ROKU INC. CLASS A
VRNA VERONA PHARMA ADS
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
AVGO BROADCOM INC.
AX AXOS FINANCIAL INC.
DELL DELL TECHNOLOGIES INC CLASS C
LC LENDINGCLUB CORP
SMCI SUPER MICRO COMPUTER
PASG INC.
BEAM PASSAGE BIO
GBIO BEAM THERAPEUTICS
FUBO GENERATION BIO
BUR FUBOTV
FHTX BURFORD CAPITAL
MRVL FOGHORN THERAPEUTICS
STX MARVELL TECHNOLOGY INC
TSVT SEAGATE TECHNOLOGY HLDGS PLC
DSGN 2SEVENTY BIO INC
GFS DESIGN THERAPEUTICS INC
PEPG GLOBALFOUNDRIES INC
BROS PEPGEN INC
PRME DUTCH BROS INC
PRIME MEDICINE INC
 PRESS RELEASE

Northrim BanCorp, Inc. Promotes Huston to President and CEO; Schierhor...

Northrim BanCorp, Inc. Promotes Huston to President and CEO; Schierhorn Remains Chairman ANCHORAGE, Alaska, March 29, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Northrim BanCorp Inc., the parent company of Northrim Bank (NASDAQ: NRIM), named Mike Huston as President and CEO of Northrim BanCorp, effective April 6, 2024. Mr. Huston will also serve as Northrim BanCorp’s Chief Operating Officer and Northrim Bank’s President and CEO. Joe Schierhorn will continue to serve as Chairman of the Board of Directors of Northrim BanCorp and Northrim Bank, a position he has held since 2018 after...

 PRESS RELEASE

Parsons Continues US Air Force Research and Development Support Throug...

Parsons Continues US Air Force Research and Development Support Through $28 Million Task Order CHANTILLY, Va., March 26, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company was awarded a $28 million cost-plus-fixed-fee contract to provide intelligence, surveillance, and reconnaissance command and control and space software baselines for the Air Force Research Laboratory’s (AFRL) Global Application Research, Development, Engineering, and Maintenance (GARDEM) program. The contract includes one three-year performance period and extends Parsons’ portfolio...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch